Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Location » Colombia

Armenia, Colombia Clinical Trials

Angina

Research Site

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Atherosclerosis

Novartis Investigative Site

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

COPD (Chronic Obstructive Pulmonary Disease)

Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dyslipidemia

Research Site

A clinical research study of AMG 145, Placebo and Effective statin therapy for the treatment of Dyslipidemia

Heart Attack (Myocardial Infarction)

Novartis Investigative Site

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Heart Disease

Research Site

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

High Blood Pressure (Hypertension)

Fundacion Cardiomet Cequin

A clinical research study of GROUP A: Valsartan plus Chlorthalidone, GROUP B: Valsartan and GROUP C: Chlorthalidone for the treatment of Hypertension

High Cholesterol (Hyperlipidemia)

Fundacion Cardiomet Eje Cafetero CEQUIN

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Lung Disease

Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lupus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Stroke

Research Site

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Novartis Investigative Site

A clinical research study of Canakinumab and Placebo for the treatment of Atherosclerosis

Systemic Lupus Erythematosus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus